Skip to main content

Vetera 4XP + WNV

This page contains information on Vetera 4XP + WNV for veterinary use.
The information provided typically includes the following:
  • Vetera 4XP + WNV Indications
  • Warnings and cautions for Vetera 4XP + WNV
  • Direction and dosage information for Vetera 4XP + WNV

Vetera 4XP + WNV

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Encephalomyelitis-Influenza-West Nile Virus Vaccine

Eastern & Western, Killed Virus

Tetanus Toxoid

Vetera 4XP + WNV Indications

product has been shown to be effective for the vaccination of healthy horses 4 months of age or older, including pregnant mares, against eastern and western encephalomyelitis (EEE & WEE), west nile virus (WNV), and tetanus, and against respiratory disease due to A2 equine influenza virus (EIV). The duration of immunity against EIV OH/03 is at least 6 months and against WNV is at least 12 months. The duration for the remaining organisms has not been determined. For more information regarding efficacy and safety data go to

This product has also been shown to be effective against shedding due to A2 EIV and against viremia, mortality, and neurologic clinical disease due to WNV.


Contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) EIV strains. Amphotericin B and gentamicin added as preservatives.

Directions and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3 to 4 weeks using a different injection site. Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. For advice on revaccination frequency, contact your veterinarian or the manufacturer.


Store at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

For use in animals only

Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

© 2019 Boehringer Ingelheim Animal Health USA Inc. All rights reserved.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/46W5.22

10 Doses/10 mL


CPN: 1028271.3

Telephone:   800-325-9167
Fax:   816-236-2717
Every effort has been made to ensure the accuracy of the Vetera 4XP + WNV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2021 Animalytix LLC. Updated: 2021-10-04